Xoma Royalty Corporation

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$42.07

+0.12 (+0.29%)

As of Jun 24, 3:15 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 6 67%

Hold 3 33%

Sell 0 0%

Price Target

Analyst Price Target -4.9% upside

Low Target $30.13

Average Target $40.02

High Target $66.99

Current Price $42.07

Current
$42.07

Target
$40.02

$30.13 $40.02 avg $66.99

Scenario Analysis

Bear Case

$30.13

-28.4%

Low target

Base Case

$40.02

-4.9%

Avg target

Bull Case

$66.99

+59.2%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$42.81

-1.7% from high

52-Week Low

$22.29

+88.7% from low

Target vs 52W High

$40.02

-6.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.7%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+189.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-7.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.0%